Evidence map›Paper›PMID 42469690›Full record

ArticleBMC medical imaging2026

Optimizing coronary artery disease management: the role of CT-derived fractional flow reserve in predicting revascularization and guiding clinical decisions.

Jian Huang, Tianyu Li, Mingrui Cui, Siyuan Lu, Jing Ye, Ji Zhang, Meng Zhu

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jian Huang *Department of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Tianyu Li *Department of Radiology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, 225001, China.
Mingrui CuiDepartment of Radiology, Affiliated Hospital with Yangzhou University, Yangzhou, 225001, China.
Siyuan LuDepartment of Radiology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, 225001, China.
Jing YeDepartment of Radiology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, 225001, China.
Ji ZhangDepartment of Radiology, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, 225300, China.
Meng ZhuDepartment of Radiology, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, 225300, China. jsntdxzm@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCoronary artery disease (CAD) is the most common heart disease, and invasive coronary angiography (ICA) has been recognized as the gold standard for diagnosing CAD. However, this method is influenced by inter-observer and intra-observer variability. The impact of machine learning (ML) algorithm-based fractional flow reserve CT (CT-FFR) software on the prediction of revascularization, the subsequent use of ICA, and the clinical decision-making for patients with suspected CAD remains to be studied. To evaluate the role of CT-FFR in the prediction of coronary revascularization and the optimization of treatment decisions.

methodsA retrospective study of 279 patients who underwent non-emergency CCTA and ICA within 90 days, with ≤ 0.80 indicating significant stenosis. Stenosis severity was categorized based on CCTA and ICA results. Consistency between CT-FFR, CCTA, and ICA was evaluated. Treatment decisions based on CT-FFR were compared to those based on CCTA and ICA, focusing on modifications between OMT and REV. The impact of CT-FFR on ICA utilization and its relationship with subsequent MACE incidence were also assessed.

resultsCT-FFR demonstrated strong consistency with ICA (84.2%) and CCTA (78.5%). Median CT-FFR values declined with increasing stenosis severity (CCTA severe stenosis: 0.71; ICA severe stenosis: 0.70 ), confirming its diagnostic reliability. Among 188 patients with positive CT-FFR results, 75.5% underwent revascularization, reflecting high predictive accuracy. Treatment strategies were modified in 75 cases compared to ICA results and 60 cases compared to CCTA, optimizing decisions between OMT and REV. CT-FFR may reduce ICA utilization by 56.0% and the number of arteries requiring revascularization by 25.0%, improving procedural efficiency and reducing unnecessary interventions. Furthermore, CT-FFR demonstrated prognostic value as patients with positive results had a higher incidence of MACE. It also enhanced decision-making for non-obstructive arteries, significantly improving patient management and clinical outcomes.

conclusions(1) CT-FFR demonstrated high consistency with the diagnostic results of both CCTA and ICA, and CT-FFR values showed a decreasing trend as the degree of stenosis increased. (2) CT-FFR based on deep learning algorithms exhibited high diagnostic performance in predicting revascularization. In addition, patients with positive CT-FFR results had approximately twice the risk of major adverse cardiovascular events (MACE) compared to those with negative results, suggesting its potential superiority in guiding ICA utilization and its promising capability for predicting clinical outcomes.

Indexed as

Clinical Decision-MakingComputed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary StenosisFractional Flow Reserve, MyocardialMyocardial RevascularizationAgedAlgorithmsFemaleHumansMachine LearningMaleMiddle AgedRetrospective StudiesSeverity of Illness IndexCoronary artery diseaseCoronary computed tomography angiographyFractional flow reserveInvasive coronary angiography

Identifiers

PMID42469690
PMCPMC13660128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.